Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The state-of-play and future of platinum drugs
Michael G. Apps, Eugene Ho Yan Choi, Nial J. Wheate
Endocrine Related Cancer (2015) Vol. 22, Iss. 4, pp. R219-R233
Open Access | Times Cited: 238

Showing 1-25 of 238 citing articles:

Cisplatin: The first metal based anticancer drug
Sumit Ghosh
Bioorganic Chemistry (2019) Vol. 88, pp. 102925-102925
Closed Access | Times Cited: 1382
The side effects of platinum-based chemotherapy drugs: a review for chemists
Rabbab Oun, Yvonne E. Moussa, Nial J. Wheate
Dalton Transactions (2018) Vol. 47, Iss. 19, pp. 6645-6653
Closed Access | Times Cited: 1375
Metal complexes in cancer therapy – an update from drug design perspective
Umar Ndagi, Ndumiso N. Mhlongo, Mahmoud E. S. Soliman
Drug Design Development and Therapy (2017) Vol. Volume11, pp. 599-616
Open Access | Times Cited: 789
Platinum-based drugs: past, present and future
Shahana Dilruba, Ganna V. Kalayda
Cancer Chemotherapy and Pharmacology (2016) Vol. 77, Iss. 6, pp. 1103-1124
Closed Access | Times Cited: 776
FOXO Signaling Pathways as Therapeutic Targets in Cancer
Mohd Farhan, Haitao Wang, Uma Gaur, et al.
International Journal of Biological Sciences (2017) Vol. 13, Iss. 7, pp. 815-827
Open Access | Times Cited: 440
Chemophototherapy: An Emerging Treatment Option for Solid Tumors
Dandan Luo, Kevin A. Carter, Dyego Miranda, et al.
Advanced Science (2016) Vol. 4, Iss. 1
Open Access | Times Cited: 394
Cisplatin and beyond: molecular mechanisms of action and drug resistance development in cancer chemotherapy
Tomaž Makovec
Radiology and Oncology (2019) Vol. 53, Iss. 2, pp. 148-158
Open Access | Times Cited: 394
Liposome-based drug co-delivery systems in cancer cells
Sepideh Zununi Vahed, Roya Salehi, Soodabeh Davaran, et al.
Materials Science and Engineering C (2016) Vol. 71, pp. 1327-1341
Closed Access | Times Cited: 275
Platinum-based chemotherapy in advanced non-small-cell lung cancer: optimal number of treatment cycles
Antônio Rossi, Massimo Di Maïo
Expert Review of Anticancer Therapy (2016) Vol. 16, Iss. 6, pp. 653-660
Open Access | Times Cited: 198
Recent advances in the synthesis, stability, and activation of platinum(IV) anticancer prodrugs
Zoufeng Xu, Zhigang Wang, Zhiqin Deng, et al.
Coordination Chemistry Reviews (2021) Vol. 442, pp. 213991-213991
Closed Access | Times Cited: 118
A chemical perspective on the clinical use of platinum-based anticancer drugs
Shoohb Alassadi, Michelle J. Pisani, Nial J. Wheate
Dalton Transactions (2022) Vol. 51, Iss. 29, pp. 10835-10846
Closed Access | Times Cited: 75
Half-Sandwich Ruthenium Arene Complexes Bearing Clinically Approved Drugs as Ligands: The Importance of Metal–Drug Synergism in Metallodrug Design
Chezhiyan Sumithaa, Mani Ganeshpandian
Molecular Pharmaceutics (2023) Vol. 20, Iss. 3, pp. 1453-1479
Closed Access | Times Cited: 41
Toward Carbon Monoxide–Based Therapeutics: Critical Drug Delivery and Developability Issues
Xingyue Ji, Krishna Damera, Yueqin Zheng, et al.
Journal of Pharmaceutical Sciences (2016) Vol. 105, Iss. 2, pp. 406-416
Open Access | Times Cited: 163
Emerging platinum(iv) prodrugs to combat cisplatin resistance: from isolated cancer cells to tumor microenvironment
Zhigang Wang, Zhiqin Deng, Guangyu Zhu
Dalton Transactions (2019) Vol. 48, Iss. 8, pp. 2536-2544
Closed Access | Times Cited: 128
The mechanism of tumour cell death by metal-based anticancer drugs is not only a matter of DNA interactions
Alberta Bergamo, Paul J. Dyson, Gianni Sava
Coordination Chemistry Reviews (2018) Vol. 360, pp. 17-33
Closed Access | Times Cited: 110
Polymeric nanoparticles for colon cancer therapy: overview and perspectives
Xinru You, Yang Kang, Geoffrey Hollett, et al.
Journal of Materials Chemistry B (2016) Vol. 4, Iss. 48, pp. 7779-7792
Closed Access | Times Cited: 106
Cytotoxicity of thymoquinone alone or in combination with cisplatin (CDDP) against oral squamous cell carcinoma in vitro
Omar M. Alaufi, Abdulwahab Noorwali, Fatheya Zahran, et al.
Scientific Reports (2017) Vol. 7, Iss. 1
Open Access | Times Cited: 99
Nitric Oxide Generated by Tumor-Associated Macrophages Is Responsible for Cancer Resistance to Cisplatin and Correlated With Syntaxin 4 and Acid Sphingomyelinase Inhibition
Cristiana Perrotta, Davide Cervia, Ilaria Di Renzo, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 89
A view on multi-action Pt(IV) antitumor prodrugs
Mauro Ravera, Elisabetta Gabano, Michael J. McGlinchey, et al.
Inorganica Chimica Acta (2019) Vol. 492, pp. 32-47
Closed Access | Times Cited: 77
Pt(II)-Thiocarbohydrazone Complex as Cytotoxic Agent and Apoptosis Inducer in Caov-3 and HT-29 Cells through the P53 and Caspase-8 Pathways
Abeer Ibrahim, Mohanad Mousa Kareem, Taghreed H. Al‐Noor, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 6, pp. 509-509
Open Access | Times Cited: 67
Application of Approved Cisplatin Derivatives in Combination Therapy against Different Cancer Diseases
Dobrina Tsvetkova, Stefka Ivanova
Molecules (2022) Vol. 27, Iss. 8, pp. 2466-2466
Open Access | Times Cited: 62
Nanoparticle-based drug delivery systems with platinum drugs for overcoming cancer drug resistance
Peng Xie, Yushu Wang, Dengshuai Wei, et al.
Journal of Materials Chemistry B (2021) Vol. 9, Iss. 26, pp. 5173-5194
Closed Access | Times Cited: 58
Bioactivity and Development of Small Non-Platinum Metal-Based Chemotherapeutics
Maria Grazia Ferraro, Marialuisa Piccolo, Gabriella Misso, et al.
Pharmaceutics (2022) Vol. 14, Iss. 5, pp. 954-954
Open Access | Times Cited: 54
Conjugates of Porphyrinoid-Based Photosensitizers with Cytotoxic Drugs: Current Progress and Future Directions toward Selective Photodynamic Therapy
Vasilii F. Otvagin, Natalia S. Kuzmina, Ekaterina S. Kudriashova, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 3, pp. 1695-1734
Closed Access | Times Cited: 53
Recent advancements in Nanotechnology-Mediated Platinum-Based cancer therapy
Asif Mohd Itoo, Balaram Ghosh, Swati Biswas
Coordination Chemistry Reviews (2024) Vol. 508, pp. 215796-215796
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top